ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

UNCY Unicycive Therapeutics Inc

1.12
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Unicycive Therapeutics Inc UNCY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.12 17:00:00
개장가 저가 고가 종가 전일 종가
1.12
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/04/202420:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
29/03/202405:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
25/03/202420:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
14/03/202420:03GLOBEUnicycive Announces $50 Million Private Placement
13/03/202420:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
08/03/202406:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
04/03/202421:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
22/02/202406:06EDGAR2Form 8-K - Current report
14/02/202421:03GLOBEUnicycive Therapeutics to Present Two Posters on..
29/01/202421:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
23/01/202421:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
23/01/202406:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202321:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
09/12/202306:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/11/202321:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
15/11/202306:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202306:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
24/10/202300:12EDGAR2Form 8-K - Current report
23/10/202320:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
26/09/202305:05EDGAR2Form 8-K - Current report
08/09/202305:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202305:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/09/202322:16EDGAR2Form 8-K - Current report
06/09/202320:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
01/09/202305:16EDGAR2Form 8-K - Current report
31/08/202305:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202320:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
15/08/202306:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
15/08/202306:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202305:15EDGAR2Form 8-K - Current report
26/07/202319:05EDGAR2Form 8-K - Current report
20/07/202320:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
18/07/202320:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
15/07/202305:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/07/202308:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/07/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/07/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/06/202306:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..
16/06/202320:38GLOBEUnicycive to Participate in the Healthcare Virtual..
16/05/202321:29GLOBEUnicycive Announces First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock